Aphton Corporation (NASDAQ:APHT) announced today that it has filed a voluntary petition under chapter 11, title 11 of the United States Bankruptcy...
Aphton Corporation (NASDAQ:APHT) announced today that on January 27, 2006, the Company received notice from The NASDAQ Stock Market informing the...
Aphton Corporation (NASDAQ:APHT) announced today that on December 27, 2005 the Company received notice from NASDAQ Stock Market informing the...
Aphton Corporation (NASDAQ:APHT) announced today that the Company has closed its previously announced transaction related to the restructuring of...
Aphton Corporation (NASDAQ:APHT) announced the formal completion of two agreements with Celltrion, Inc., South Korea for the licensing and...
Aphton Corporation (NASDAQ: APHT) announced today that effective November 15, 2005, the Company adopted a mandatory retirement policy for the...
Aphton Corporation (NASDAQ: APHT) today reported financial results for the third quarter ended September 30, 2005. The company ended the third...
Dissolution Allows for New Partnership Opportunities and Further Development of Insegia in Gastric Cancer ? Aphton Corporation (NASDAQ:APHT...
Aphton Corporation (NASDAQ:APHT) announced today that the Company entered into a binding letter agreement with the holders of the Company's $20...
Aphton Corporation (NASDAQ:APHT), a biotechnology company focused on the development of immunotherapies for the treatment of cancer, announced...
Aphton Corporation (NASDAQ: APHT) announced today that on October 26, 2005, the Company received notice from The Nasdaq Stock Market informing the...
Aphton Corporation (NASDAQ: APHT) today reported financial results for the second quarter ended June 30, 2005. The company ended the second...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.